Liver Cancer in Dogs: Hepatocellular Carcinoma Treatment Guide

Last updated: May 16, 2026

Understanding Liver Cancer in Dogs

Liver cancer in dogs is a category that sounds singular but actually covers several quite different diseases. The liver is a large, multifunctional organ that processes nutrients, filters toxins, makes blood-clotting proteins, and produces bile. Tumors that arise within the liver can come from the liver cells themselves (hepatocellular carcinoma), from the bile ducts (cholangiocellular carcinoma), or from supporting tissues (sarcomas). The liver is also a common site for metastasis from other cancers, so finding a liver mass on ultrasound does not always mean primary liver cancer.

Hepatocellular carcinoma (HCC) is the most common primary malignant liver tumor in dogs. Its biological behavior depends heavily on its growth pattern. Massive HCC (a single large tumor confined to one liver lobe) often carries a much better prognosis than nodular HCC (multiple smaller tumors spread across lobes) or diffuse HCC (tumor infiltrating throughout the liver parenchyma). The growth pattern, more than tumor type alone, often determines treatment options and outlook.

Massive vs Nodular vs Diffuse Forms

The massive form is what oncologists hope to see when they review imaging. A single large mass confined to one of the liver lobes can often be removed surgically with curative intent. The lobe is excised, the rest of the liver continues to function, and the dog can sometimes live for years with minimal further intervention. Hepatic regenerative capacity is remarkable; dogs tolerate liver lobectomy surprisingly well.

The nodular form, with multiple discrete tumors scattered through the liver, is much harder to treat surgically because not all of the affected tissue can be removed without leaving inadequate functional reserve. The diffuse form, where tumor infiltrates throughout the liver, is generally not amenable to surgery and carries the most guarded prognosis. These two patterns are more often managed with chemotherapy, supportive care, and quality-of-life-focused management. The classification matters because the treatment plan and prognosis flow directly from it.

Bile Duct and Other Liver Tumors

Cholangiocellular carcinoma arises from the bile ducts within the liver and tends to be more aggressive than HCC, with higher rates of metastasis. Hepatic carcinoid is a rarer neuroendocrine tumor of the liver. Hemangiosarcoma can arise primarily in the liver, though it more often shows up there as metastasis from a primary spleen or heart tumor. Lymphoma can also involve the liver as part of a systemic process. Each of these has its own behavior and treatment considerations, which is why histopathology matters so much.

Benign liver lesions also occur. Hepatic adenomas, regenerative nodules, and cysts are all part of the differential when a liver lesion is found. Imaging alone usually cannot reliably distinguish benign from malignant, so tissue sampling is generally needed for definitive diagnosis. For broader context on cancer, see our cancer in dogs overview.

Risk Factors and Predisposed Breeds

Liver cancer in dogs is mostly a disease of senior pets, with most affected dogs being older than ten years at diagnosis. Males may be slightly more often affected than females in some studies. Breed predisposition is less well-defined than for some other canine cancers, but case reports include over-representation of medium-to-large breeds. Chronic hepatitis, cirrhosis, and long-term hepatic inflammation may increase risk over time.

There is no proven preventive intervention, but routine senior wellness exams that include physical exam (palpating for cranial abdominal organomegaly) and periodic bloodwork can pick up early changes. Elevated liver enzymes on routine bloodwork sometimes prompt the imaging that finds an early, surgically resectable tumor. Pet insurance taken out before symptoms appear remains a strong financial-protection tool for any senior cancer diagnosis.

Recognizing the Warning Signs

Liver tumors in dogs are often clinically silent in early stages. By the time symptoms appear, the tumor is usually large or there are multiple tumors. Common signs include lethargy, decreased appetite, weight loss, and a distended abdomen. Some owners notice an asymmetrical fullness in the cranial abdomen on the left or right side, depending on which lobe is affected.

Other signs may include vomiting, diarrhea, jaundice (yellowing of the gums, skin, or whites of the eyes), polyuria and polydipsia (increased drinking and urination), and weakness. Some dogs present in collapse or with hemoabdomen if a large hepatic mass ruptures. Hypoglycemia (low blood sugar) is occasionally a paraneoplastic syndrome that can cause weakness or seizures. Any senior dog with persistent vague abdominal symptoms or unexplained jaundice deserves prompt veterinary evaluation.

Diagnostic Workup

The workup typically begins with thorough history, physical exam (especially abdominal palpation), and routine bloodwork including a complete blood count, chemistry panel, coagulation profile, and urinalysis. Liver enzymes (ALT, ALP, GGT) are often elevated, and bilirubin may be high if biliary obstruction is present. Bile acids testing helps assess overall liver function. Coagulation testing is important because liver tumors can disrupt clotting and surgery is risky in coagulopathic patients. Vitamin K administration is sometimes used pre-operatively if coagulation parameters are mildly off.

Abdominal ultrasound is the centerpiece of imaging. It identifies the size, location, and number of liver lesions, and gives clues about whether the pattern is massive, nodular, or diffuse. CT imaging is increasingly used for surgical planning, particularly for massive HCC where lobe boundaries and vascular involvement matter. Three-view chest radiographs screen for metastasis. Definitive diagnosis comes from fine-needle aspirates, ultrasound-guided biopsy, or surgical biopsy. Ask your primary vet for a referral to a board-certified oncologist (ACVIM-Oncology) once the diagnosis is suspected.

Treatment Options

For massive HCC, surgical liver lobectomy is the treatment of choice and can be curative or near-curative. Most dogs tolerate the surgery well, recover within a few weeks, and live for years afterward. Outcomes for properly selected massive HCC cases are among the most encouraging in canine oncology. Surgery should be performed by a board-certified surgeon (ACVS) with experience in hepatic procedures because hepatic surgery requires meticulous attention to vascular anatomy and hemostasis.

For nodular and diffuse forms, chemotherapy is the more common approach, though responses are typically partial and durable cures are uncommon. For cholangiocellular carcinoma and hepatic hemangiosarcoma, treatment generally combines surgery (when possible) with chemotherapy. For hepatic lymphoma, chemotherapy is the primary treatment. Palliative care, including pain control, anti-nausea medications, appetite stimulants, and supportive nutritional therapy, plays a role across all forms.

Newer interventional radiology techniques, such as transarterial chemoembolization (TACE) and bland embolization of the hepatic arterial supply to a tumor, are available at some specialty centers and may be options for select non-resectable cases. These minimally invasive procedures use catheter-based delivery of chemotherapy or embolic agents directly to the tumor and are typically performed by veterinary interventional radiologists. Discuss with your oncologist whether referral to a center offering these techniques is appropriate for your dog.

Prognosis and Quality of Life

Prognosis varies enormously by tumor type and growth pattern. Massive HCC after successful lobectomy carries a good prognosis, with many dogs living two or more years after surgery and some essentially cured. Nodular and diffuse HCC carry guarded-to-poor prognoses, with survival typically measured in months. Cholangiocellular carcinoma generally has a poorer prognosis than HCC due to higher metastatic rates. Hepatic hemangiosarcoma is aggressive with short survival times. Hepatic lymphoma can respond well to chemotherapy.

Quality of life is the most important metric throughout. A dog who is eating, comfortable, and engaging with the household is doing well regardless of imaging findings. The ASPCA Pet Loss Hotline at 877-474-3310 is a resource for families navigating end-of-life decisions for cancer patients. Hospice and palliative care services are reasonable supplements to in-person veterinary care.

Living with a Dog Diagnosed with Liver Cancer

Day-to-day management focuses on supporting liver function, maintaining nutrition, and watching for complications. Dietary management often includes a moderately protein-restricted diet for dogs with significant liver dysfunction, though this is individualized and your vet may not restrict protein at all in early-stage disease. Anti-nausea medications, appetite stimulants, and anti-vomiting drugs are commonly prescribed to keep dogs eating. Some dogs benefit from supplements such as SAMe and silybin (milk thistle compounds), often combined in veterinary products, to support hepatocyte function. Always discuss any supplement with your vet before starting.

Recheck visits typically include bloodwork to monitor liver enzymes and overall organ function, and periodic imaging to monitor tumor size and screen for metastasis. Communicate any worsening signs (jaundice, vomiting, lethargy, neurologic changes that could suggest hepatic encephalopathy) promptly. Hepatic encephalopathy in particular is an emergency and warrants same-day evaluation.

Cost, Adoption, and the Bigger Picture

Treating liver cancer is expensive. Diagnostic imaging, biopsy, surgery, chemotherapy, hospitalizations, and follow-up visits can total many thousands of dollars. Specific dollar figures vary by region and complexity. Ask your vet about cost ranges in your area, and consider CareCredit, scratchpay, payment plans, and pet insurance bought before symptoms appear. Our veterinary specialist cost breakdown walks through realistic ranges for these services.

If you are an adopter considering a senior dog, the cancer reality should not be a deterrent. Senior dogs are some of the most rewarding adoptions in any rescue. Browse our adopt-a-dog hub for senior dogs looking for soft landings, and connect with your primary vet from day one for senior wellness planning.

Frequently Asked Questions

What is the most common liver cancer in dogs?

Hepatocellular carcinoma (HCC) is the most common primary malignant liver tumor in dogs. Its growth pattern (massive, nodular, or diffuse) significantly affects prognosis and treatment options.

Can liver cancer in dogs be cured?

Massive HCC, where a single large tumor is confined to one liver lobe, can often be cured by surgical lobectomy. Nodular and diffuse forms are typically not curable, but quality time can still be gained with appropriate management.

What are the first signs of liver cancer in dogs?

Lethargy, decreased appetite, weight loss, abdominal distension, and elevated liver enzymes on routine bloodwork are common early signs. Many cases are detected because of bloodwork abnormalities before any obvious symptoms develop.

How is liver cancer diagnosed in dogs?

Diagnosis typically involves bloodwork, abdominal ultrasound, possibly CT imaging, chest radiographs for staging, and biopsy or fine-needle aspirate for histopathology. Coagulation testing is important before any biopsy.

Will my dog tolerate liver surgery?

Most dogs tolerate liver lobectomy surprisingly well thanks to the liver’s remarkable regenerative capacity. Recovery typically takes a few weeks. The procedure should be performed by a board-certified surgeon experienced in hepatic procedures.